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Abstract 
Background: Published data suggest that asthma is significantly under/misdiagnosed. The present community-
based study performed in Italy aims at investigating the level of asthma under/misdiagnosis among patients referring 
to the General Practitioner (GP) for respiratory symptoms and undergoing Inhaled corticosteroids.
Methods: A sub-analysis of a previously published observational cross-sectional study has been provided. It included 
subjects registered in the GP databases with at least three prescriptions of inhaled or nebulised corticosteroids dur-
ing the 12 months preceding the start of the study. All subjects, independently of the diagnosis, were invited to visit 
their GP’s office for a standardised interview and to fill the European Community Respiratory Health Survey (ECRHS) 
questionnaire.
Results: The studies involved 540 GPs in most of the Italian regions and 2090 subjects (mean age 54.9 years, 54.1 % 
females) were enrolled. Among them 991 cases of physician-diagnosed asthma were observed while 1099 subjects 
received a diagnosis other than asthma (chronic obstructive pulmonary disease, chronic upper respiratory tract infec-
tions etc.). Among the lasts, the ECRHS questionnaire was suggestive for asthma diagnosis in 365 subjects (33.2 %).
Conclusions: The data suggest that there is still a large under/misdiagnosis of asthma in the Italian primary care 
setting, despite the spread of GINA guidelines nearly 20 years before this study. A validated tool like the ECRHS ques-
tionnaire has detected a considerable proportion of potentially asthmatic patients who should be addressed to lung 
function assessment to confirm the diagnosis. Further educational efforts directed to the GPs are needed to improve 
their diagnosis of asthma (SAM104964).
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Background
A significant asthma under/misdiagnosis has been 
highlighted by some Italian studies. Ciprandi et  al. [1] 
investigated the epidemiological features of asthma in a 
homogeneous population of 18-year-old male conscripts 
referred to La Spezia Military Navy Hospital for a call-
up visit and found a not negligible under-diagnosis and 
inadequate treatment of asthma. In 7.4  % of conscripts 
asthma had been newly diagnosed during the study and 
about one quarter of the asthmatic subjects received no 
treatment at all. Bellia et  al. [2] showed that asthma in 
the elderly is frequently confused with chronic obstruc-
tive pulmonary disease (COPD) and that in patients 
with mild functional impairment asthma may be under-
diagnosed. A decreased perception of dyspnoea, or the 
intermittent onset of asthma symptoms, may account for 
under/misdiagnosis or delayed diagnosis of the disease 
[3]. Under/delayed-diagnosis and consequent under/
delayed-treatment start might be important factors con-
tributing to asthma morbidity, whereas early detection 
and treatment of asthma might improve the long-term 
prognosis of these patients.
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The European Community Respiratory Health Survey 
(ECRHS) questionnaire has been proposed as a validated 
tool useful in identifying asthmatic patients [4–6]. The aim 
of the present community-based study was to investigate 
the level of asthma under/misdiagnosis in a primary care 
setting, by comparing physician diagnosis and the ECRHS 
questionnaire results. Patients undergoing inhaled cor-
ticosteroids (ICS) for a physician-diagnosed respiratory 
disease other than asthma were included as the study pop-
ulation. The results are reported as a sub-analysis of a pre-
viously published observational cross-sectional study [7].
Methods
Full details of the study design and patient population 
have been reported elsewhere [7] and are summarised 
here.
Study design
A multicentre, observational cross-sectional study 
involving of 540 Italian General Practitioners (GPs) has 
been conducted. The protocol was approved by the Ethic 
Committee of the Italian Society of General Medicine 
(SIMG; http://www.simg.it). Written informed consent 
was obtained by each patient before the inclusion into 
the study. Invitation to participate to the study was sent 
to all the GPs owning a computerised patient database 
according to the information stored in the archive of the 
European School of General Medicine (Scuola Europea 
di Medicina Generale, SEMG, Firenze, Italy).
Adult patients (≥18-years old) diagnosed with a respira-
tory disease and receiving at least 3 prescriptions of inhaled 
corticosteroids (ICS) during the previous 12  months 
(metered-dose inhaler -MDI-, dry powder inhaler -DPI- 
or nebulise) were enrolled. A concomitant prescription 
including long-acting beta2 agonists and/or theophylline 
and/or nedocromil or sodium cromoglycate, and/or anti-
leukotrienes, and/or anticholinergic drugs was considered 
as an exclusion criterion, as usually these drugs are specifi-
cally and unequivocally prescribed for asthma or COPD.
This study was performed from September 2005 to Jan-
uary 2006. Every participating physician was requested 
to retrospectively select the last ten eligible consecutive 
patients since the study beginning date.
The selected patients were invited to perform a follow-
up visit and to fill in an ECRHS respiratory symptom 
questionnaire. The first page contains validated questions 
on the presence of asthma and asthma-like symptoms, 
frequency of asthma attacks, age at onset and remis-
sion of asthma, doctor diagnosis of asthma, presence 
of chronic cough and phlegm, and smoking habits. The 
second page collects information on the last 12 months 
about: indirect costs (number of working days lost and 
number of impaired general activity days resulting from 
asthma); type and frequency of doctor visits and labo-
ratory tests performed because of asthma; frequency of 
hospital admissions and emergency department (ED) vis-
its resulting from asthma; treatment; type of prescription 
(when needed or for daily use) [4–6]. A subject with a 
questionnaire positive for respiratory symptoms (wheez-
ing, nocturnal chest tightness, attack of breathlessness 
after activity at rest or at night; or 1 asthma attack) was 
considered a subject with current asthma.
Results
Overall a response rate of 89  % was recorded corre-
sponding to 2090 subjects (mean age 54.9 years, 54.1 % 
females). Among these subjects, according to the physi-
cian diagnosis 991 were affected by asthma and 1099 suf-
fered from a respiratory disease other than asthma.
Table  1 shows demographic and clinical data of 
enrolled patients: comorbidities, such as cardiovascular 
diseases, are more frequently reported in patients with 
diagnosis other than asthma, whereas the prevalence of 
allergic disorders is higher in patients with asthma.
In patients diagnosed with a respiratory disease other 
than asthma, COPD was the most frequently reported 
(21.7 %), followed by not specified upper respiratory tract 
infections (12.2 %), chronic or acute bronchitis (11.5 %). 
Overall, upper respiratory symptoms and/or signs were 
present in around 40  % of these patients, classified as 
allergic or vasomotor rhinitis, chronic otitis/sinusitis, 
not specified otitis/sinusitis, not specified rhinitis, not 
specified acute upper respiratory tract infections and 
not specified upper respiratory tract infections. In 4.9 % 
other different respiratory diseases were reported.
Table 1 Main characteristics of the patients with diagnosis 
with diagnosis other than asthma [N = 1099]
% accounting also for missing data
Missing data: smoking habits = 20
N (%) 95 % IC
Mean age [years (SD)] 58.4 (18.3)
Mean age at diagnosis of asthma (SD) – –
Female [n (%)] 590 (53.7) 50.6–56.6
Smoking habits
 Non smokers [n (%)] 614 (55.9) 52.8–58.8
 Past smokers [n (%)] 199 (18.1) 15.8–20.5
 Current smokers [n (%)] 277 (25.2) 22.6–27.8
Smoking history, mean years (SD) (14.1) 10.8 –
Concomitant diseases
 Cardiovascular 445 (40.5) 37.5–43.4
 Respiratory 119 (10.8) 9.0–12.8
 Ear nose and throat (ENT) 171 (15.6) 13.4–17.8
Allergy 103 (9.4) 7.7–11.2
Spirometry 181 (16.5) 14.3–18.7
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Among patients diagnosed with a respiratory disease 
different from asthma (1099), the ECRHS asthma ques-
tionnaire suggested asthma diagnosis in 365 (33.2  %) of 
them (Fig.  1). The characteristics of this subgroup are 
reported in Table  2. Most diagnoses (about 60  %) were 
related to chronic obstructive lung diseases, bronchi-
tis (chronic or acute bronchitis), whereas around 20  % 
were related to high respiratory airways (acute or chronic 
upper respiratory tract infections, allergic or vasomo-
tor rhinitis, otitis/sinusitis). Of note, only 16.5  % of 
patients had undergone lung function assessment in the 
last 12 months. In particular, less than 30 % of asthmatic 
patients according to the ECRHS questionnaire and 
38.6 % of physician-diagnosed asthmatic patients under-
went spirometry (Table 1).
Discussion
Our study highlights that according to the ECRHS 
results, asthma should be highly suspected in 33.2  % in 
patients diagnosed with a respiratory disease different 
from asthma by their GP and undergoing ICS treatment. 
Furthermore only 16.5  % of the overall study popula-
tion had undergone lung function assessment in the last 
12 months, despite suffering from a physician-diagnosed 
respiratory disease.
The results of our study show a poor accordance 
between physician-reported and ECRHS questionnaire-
related asthma diagnosis. Assuming the good sensibility 
and specificity of the ECRHS questionnaire, the results 
confirm that Italian GPs do not optimally recognise 
respiratory symptoms as asthma manifestations. This 
finding is in agreement with previous studies, showing 
that 7.4 % of enrolled subjects had been newly diagnosed 
with asthma during the study and about one quarter of 
the asthmatic subjects received no treatment at all [1].
It is not surprising that in our cohort of patients, 
selected on the basis of ICS use, many of them had a 
diagnosis different from asthma. In Italy, patients with 
COPD, acute and chronic bronchitis, acute upper respir-
atory tract infections, rhinitis or not well defined respira-
tory symptoms are extensively treated with ICS, as also 
reported in other studies, including a large-scale paediat-
ric survey [8].
Among the patients identified as asthmatics accord-
ing to ECRHS questionnaire, 35  % had a diagnosis of 
COPD in GP database, although around 56  % of them 
had never smoked. Distinguishing asthma from COPD 
is often problematic, particularly in smokers and older 
adults, and in a significant proportion of patients COPD 
and asthma features may coexist [9]: spirometry, besides 
clinical history, could help to address the question of dif-
ferential diagnosis, and it should always be performed 
in patients with respiratory symptoms. Nevertheless in 
our study less than 30 % of asthmatic patients according 
to the ECRHS questionnaire and 38.6  % of physician-
diagnosed asthmatic patients underwent lung function 
assessment during the previous 12 months. Limited pre-
scription of lung function tests in general practice (physi-
cians may not be fully familiar with the interpretation of 
results) and poor accessibility to spirometers, which are 
mostly available in the hospital setting due to lack of time 
to perform office spirometry (in most cases GPs in Italy 
do not have technical or nursing support), may account 
Fig. 1 Results from the ECRHS questionnaire administered to patient 
with respiratory symptoms and diagnosis other than asthma in the 
GP database
Table 2 Diagnosis reported in the GP data base of the 365 
subjects identified as asthmatics by ECRHS questionnaire
n.s. not specified
Diagnosis Patients (n) %
COPD 128 35.1
Chronic bronchitis or acute bronchitis 53 14.5
Respiratory symptoms or signs 47 12.9
Upper respiratory tract infections (n.s.) 21 5.8
Acute bronchitis 20 5.5
Bronchitis n.s. 15 4.1
Allergic or vasomotor rhinitis 11 3.0
Chronic upper respiratory tract infections 10 2.7
Chronic otitis/sinusitis 10 2.7
Acute upper respiratory tract infections (n.s) 10 2.7
Otitis/sinusitis (n.s.) 8 2.2
Other respiratory diseases 32 8.8
Total 365 100.0
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for under-utilization of spirometry in primary care [10, 
11].
Around 20  % of the patients identified as asthmat-
ics according to ECRHS questionnaire had a diagnosis 
of upper airway disease in the GP database (allergic or 
vasomotor rhinitis or otitis/sinusitis). It is well known 
that allergic rhinitis and sinusitis are often associated 
with asthma and constitute the main risk factor for its 
development. Another Italian study showed that sub-
jects with allergic rhinitis show an eightfold risk of hav-
ing asthma compared to subjects without allergic rhinitis 
[12]. Furthermore, in a large cohort study on subjects with 
allergic rhinitis without diagnosis of asthma, bronchial 
hyper-responsiveness and also bronchial obstruction were 
detected in a high percentage of patients, both during and 
outside the pollen season [13], underlining the impor-
tance of lung function assessment in patients with chronic 
upper airways symptoms. Nevertheless the lack of asthma 
identification in these patients suggests that asthma is still 
regarded mainly as an intermittent disease, or misrecog-
nized as a clinical manifestation of viral infections.
Our study has some potential limitation. Firstly, only 
patients on ICS treatment were included in the survey, 
whereas those treated with other respiratory drugs were 
excluded. Although inhaled corticosteroids are the gold 
standard of asthma therapy, in general practice there is 
a wide range of treatments for patients with respiratory 
symptoms. Thus, the rate of mis/underdiagnosis of asthma 
observed in this study presumably affects milder patients. 
As regards patients treated with various anti-asthmatic 
agents, such as combinations of ICS and bronchodilators, 
recent evidence suggests a considerable amount of overdi-
agnosis of asthma [14]. Secondly, untreated patients were 
excluded from the study population, thus patients with 
milder disease have been potentially lost.
Our data suggest that there is still a considerable 
under/misdiagnosis of asthma in the Italian primary care 
settings, and that the use of a validated questionnaire 
could be of helpful in identifying patients to address to 
lung function assessment.
Conclusions
Asthma under/misdiagnosis and consequent inappropri-
ate pharmacological treatment still affect asthma man-
agement. Furthermore they represent important factors 
contributing to asthma morbidity and mortality, whereas 
early detection and management might improve the long-
term prognosis of affected patients. Educational efforts 
should be directed to improve the capability of primary 
care professionals, particularly GPs, to recognise asthma 
symptoms and to address patients to the correct diagnos-
tic work-up and proper treatment. The use of a validated 
questionnaire could be of help for patients’ identification.
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